4 September 2015
It has been discovered that people with type two diabetes who undergo bariatric or metabolic surgery tend to have better long-term outcomes than those who have standard, less invasive treatments to manage the condition.
A team of researchers from King’s College London and the Universita Cattolica in Rome examined the quality of health outcomes over five years for both groups. They found that those who had surgery were less likely to suffer from complications of diabetes, and were more likely to be able to manage it with minimal medical intervention.
This includes the use of insulin and other drugs, meaning that the surgery could significantly cut the cost of treating diabetes in the long term.
Lead researcher Francesco Rubio said: “The results of this study add to a growing body of evidence showing that the gastrointestinal tract is a rational biological target for antidiabetic interventions and support implementation of surgery as a standard option in the treatment of type two diabetes.”
Posted by Philip Briggs
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.